HIV and the returning expatriate

Journal of Travel Medicine

Volumn 6, Issue 2, 1999, Pages 99-106

  Jones, Michael E ^a,b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b Care for Mission   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LIVER ENZYME;

CONFIDENTIALITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; RISK FACTOR; SEROPREVALENCE;

EID: 0033007737     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1999.tb00840.x     Document Type: Review

References (47)

1. The World Health Report 1997 - Executive Summary, WHO Geneva, 1997.
2. Anon AIDS and HIV-1 infection in the United Kingdom: monthly report. Commun Dis Rev 1996; 6:141-144.
3. Anon AIDS and HIV in Scotland 1996: a summary. SCHIEH Weekly Report 1997; 31:33.
4. Schouten EJ, Borgdorff MW. Increased mortality among Dutch development workers. BMJ 1995; 311:1343-1344.
5. Wilson ME, Von Reyn CF, Fineberg HV. Infections in HIV-Infected Travellers: risks and prevention. Ann Intern Med 1991; 114:583-592.
6. Van Gompel A, Kozarsky P, Colebunders R. Adult travelers with HIV infection. J Travel Med 1997; 4:136-143.
7. Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997; 336:1072-1078.
8. Dallabetta G, Diomi MC. Treating sexually transmitted diseases to control HIV transmission. Curr Opin Infect Dis 1997; 10:22-25.
9. Friedland GH, Klein RS. Transmission of the human immunodeficiency virus. N Engl J Med 1987; 317:1125-1135.
10. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion associated infection with human immunodeficiency virus: factors influencing the rate of progression to disease. N Engl J Med 1989; 321:947-952.
11. Stokes P. Nurse who caught AIDS in African mission is dead Daily Telegraph, 18th April, 1995:5.
12. Miller R, Lipman M. HIV pre-test discussion. BMJ 1996; 313:130.
13. Department of Health, Guidelines for pre-test discussion on HIV testing. PL/CMO/(96)1 London: Department of Health, 1996.
14. Anon. Medical, social, sexual, financial and ethical problems with AIDS - a case history. Postgrad Med J 1997; 73:521-522.
15. Schneider MME, Hoepelman AIM, Schattenkerk JKME, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327:1836-1841.
16. Clumeck N. Primary prophylaxis against opportunistic infections in patients with AIDS. N Engl J Med 1995; 332:739-780.
17. De Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994; 331:341-346.
18. Johnson A. Condoms and HIV transmission. N Engl J Med 1994; 331:39126.
19. European Collaborative Study, Caesarean Section and the risk of vertical transmission of HIV-1. Lancet 1994; 343:1464-1467.
20. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-1180.
21. Vermund SH. Transmission of HIV-1 among adolescents and adults. In: DeVita VT, Hellman S, Rosenberg SA, eds. AIDS - etiology, diagnosis, treatment and prevention. Philadelphia: JB Lippincott Company, 1997:149.
22. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337:725-733.
23. General Medical Council. HIV infection and AIDS: the ethical considerations General Medical Council, 178-202, Great Portland Street, London W1N 6JE.
24. Mok J. Infants and children at risk of HIV infection - Guidance Notes for Carers, Paediatrics AIDS Resource Centre Edinburgh, UK.
25. Safai D. Non-infectious organ specific complications of HIV infection. In: DeVita VT, Hellman S, Rosenberg SA, eds. AIDS - etiology, diagnosis, treatment and prevention. Philadelphia: JB Lippincott Company, 1997:394-395.
26. Vestey JP, Savin JA. Psoriasis worsened by anti-malarial prophylaxis. J Infect 1992; 24:211-212.
27. Schacker T, Corey L. Herpes infection in individuals with HIV infection. In: DeVita VT, Hellman S, Rosenberg SA, eds. AIDS - etiology, diagnosis, treatment and prevention. Philadelphia: JB Lippincott Company, 1997:270.
28. Huang YQ, Li JJ, Kaplan MH, et al. Human herpes virus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345:759-761.
29. Goodwin GM, Pretsell DO, Chiswick, et al. The Edinbugh cohort of HIV positive injecting drug users at 10 years after infection: a case-control study of the evolution of dementia. AIDS 1996; 10:431-440.
30. Carne CA, Tedder RS, Smith A, et al. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet 1985; ii:1206-1208.
31. Jindal R, Solomon M, Burrows L. False positive tests for HIV in a woman with Lupus and renal failure. N Engl J Med 1993; 328:1281-1282.
32. Loussert-Ajaka I, Ly TD, Chaix ML, et al. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994; 343:1393-1394.
33. Metcalf JA, Davey RT, Lane HC. Acquired immunodeficiency syndrome: serologic and virologic tests. In: DeVita VT, Hellman S, Rosenberg SA, eds. AIDS - etiology, diagnosis, treatment and prevention. Philadelphia: JB Lippincott Company, 1997:178.
34. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328:327-335.
35. Imagawa DT, Lee MH, Wolinsky SM, et al. Human immunodeficiency virus type 1 infection in homosexual men who remain sero-negative for prolonged periods of time. N Engl J Med 1989; 320:1458-1462.
36. CDC. Interpretation and use of the Western Blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989; 38(S-7):1-7.
37. Phillips AN, Lee CA, Elford J, et al. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337:389-392.
38. O'Brien WA, Hartigan PM, Martin DM, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334:426-431.
39. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996; 335:1091-1098.
40. Sherr L. The experience of grief: psychological aspects of grief in AIDS and HIV infection. In: Grief and AIDS,Chichester: John Wiley and Sons, 1995:5-8.
41. 6/l, and death from AIDS. BMJ 1994; 309:1535-1537.
42. Jolles S, De Loes SB, Johnson MA, Janossy G. Primary HIV-1 infection: a new medical emergency? BMJ 1996; 312:1243-1245.
43. Duckett M, Orkin AJ. AIDS-related migration and travel policies and restrictions: a global survey. AIDS 1989; 3(Suppl 1):S231-252.
44. Lifson AR, Hessol NA, Buchbinder SP, et al. Serum Beta 2 microglobulin and prediction of progression to AIDS in HIV infection. Lancet 1992; 339:1436-1440.
45. Pape JW, Jean SS, Hafner A, Johnson WD. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342:268-272.
46. Glesby MJ. Immunizations during HIV infection. Curr Opin Infect Dis 1998; 11:17-21.
47. HIV Testing Requirements for Entry into Foreign Countries, US State Department Publications http://travel.state.gov/HIVtestingreqs.html.